Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,560.00
Bid: 4,560.00
Ask: 4,680.00
Change: 110.00 (2.44%)
Spread: 120.00 (2.632%)
Open: 4,540.00
High: 4,660.00
Low: 4,540.00
Prev. Close: 4,510.00
CAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Duncan Lawrie

19 Dec 2016 07:00

RNS Number : 2000S
Camellia PLC
19 December 2016
 

 

19 December 2016

 

Camellia Plc

 

Duncan Lawrie Private Bank ("Duncan Lawrie") - Update on Duncan Lawrie, sale of loan book and sale of Duncan Lawrie Asset Management

 

 

As highlighted in the recent interim report, lower interest rates and other factors have changed the outlook for private banking. This, coupled with its conservative risk appetite and opportunities for investment elsewhere in the group, has led Camellia Plc (the "Group") to review its earlier decision to invest further in Duncan Lawrie and it has therefore now decided to sell most of the Duncan Lawrie businesses.

The majority of Duncan Lawrie's UK loans and certain of its Isle of Man loans (the "Loan Book") have been sold to Arbuthnot Latham & Co. Limited for a cash consideration of £42.7 million, which equates to 95% of the value of the outstanding loans of £44.9 million. A subsequent orderly wind down of Duncan Lawrie's deposit taking and other banking operations in the UK and Isle of Man is proposed. Following this sale, Duncan Lawrie is fully funded to return all cash balances to clients.

Duncan Lawrie has also reached an agreement, subject to regulatory approval, to sell Duncan Lawrie Asset Management Limited to Brewin Dolphin Limited ("Brewin Dolphin"), a subsidiary of Brewin Dolphin Holdings Plc, for a cash consideration of £28.0 million.

Brewin Dolphin is one of the UK's leading discretionary wealth managers with over £35bn of funds under management and a long-term commitment to the market. As part of the transaction, the portfolio management team of Duncan Lawrie Asset Management Limited will move to Brewin Dolphin, providing continuity of service for clients and access to Brewin Dolphin's broader investment management and financial planning offering.

Camellia believes that both purchasers share the same high regard for client service as Duncan Lawrie and that in agreeing these sales, this should mitigate, as far as possible, the impact of these changes on clients and staff.

Discussions are underway with a number of other parties in respect of the sale of Duncan Lawrie's Isle of Man offshore trust services business.

The proceeds from these disposals will be used to repay depositors, meet any other liabilities of Duncan Lawrie and for investment in other parts of the Group.

The trading profits relating to the Loan Book in the year ending 31 December 2015 were £1.3 million and £0.8 million in the six months to 30 June 2016. The trading profits relating to Duncan Lawrie Asset Management in the year ending 31 December 2015 were £2.2 million and £0.6 million in the six months to 30 June 2016. These figures include costs which are not being transferred to the purchaser. The losses before taxation relating to the whole of Duncan Lawrie for the year ended 31 December 2015 were £3.6 million and £2.8 million in the six months to 30 June 2016.

The loss arising on sale of the Loan Book and significant closure costs of any proposed wind-down of Duncan Lawrie will be reflected in Camellia's financial results for the year ended 31 December 2016. The expected profit on disposal of Duncan Lawrie Asset Management and further operating costs relating to the proposed wind down will be reflected in Camellia's financial results for the year ended 31 December 2017.

Terms of the Loan Book sale

£34.7 million of the consideration is payable on completion today, with the balance of £8.0 million payable following novation or assignment of certain loan agreements which is expected to occur on 31 January 2017 ("Migration"). The consideration is subject to various adjustments on and shortly after Migration for loan repayments, advances and debt servicing costs in the period between 31 October 2016 and Migration.

Terms of the Duncan Lawrie Asset Management sale

Duncan Lawrie has agreed, subject to regulatory approval, to sell its wealth management business, Duncan Lawrie Asset Management Limited, but will retain the liabilities relating to the business, for £28.0 million payable at completion. The consideration is subject to a working capital adjustment.

This announcement contains inside information for the purpose of Article 7 of the Market Abuse Regulation (EU) N0. 596/2014

 

 

For further information:

 

Camellia Plc 01622 746655

Tom Franks, CEO

Susan Walker, CFO

 

Fenchurch Advisory Partners LLP 020 7382 2222

Financial Adviser on the Duncan Lawrie Asset Management sale

Richard Locke

KPMG 020 7311 1000

Financial Adviser on the Loan Book sale

Andrew Jenke

Arun Sharma

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Andrew Godber

Erik Anderson

 

Maitland

William Clutterbuck 020 7379 5151

 

 

Fenchurch Advisory Partners LLP ("Fenchurch"), which is authorised and regulated by the FCA, is acting exclusively for Camellia plc and no-one else in connection with the sale of Duncan Lawrie Asset Management Limited and will not be responsible to anyone other than Camellia plc for providing the protections afforded to clients of Fenchurch nor for providing advice in relation to the sale of Duncan Lawrie Asset Management Limited or any other matters referred to in this announcement.

 

KPMG LLP, which is authorised and regulated in the UK by the FCA for investment business activities, is acting exclusively for Duncan Lawrie Holdings Limited (a subsidiary of Camellia plc) and no-one else in connection with the sale of the Loan Book and will not be responsible to anyone other than Duncan Lawrie Holdings Limited for providing the protections afforded to clients of KPMG LLP nor for providing advice in relation to the sale of the Loan Book or any other matters referred to in this announcement.

 

Panmure Gordon (UK) Limited is authorised and regulated in the United Kingdom by the FCA. Panmure Gordon (UK) Limited is acting as nominated adviser exclusively for Camellia plc and no one else in connection with the Disposals (as defined herein) and will not regard any other person as its client in relation to the Disposals and will not be responsible to anyone other than Camellia plc for providing the protections afforded to clients of Panmure Gordon (UK) Limited, nor for providing advice in relation to any matter referred to herein.

 

Forward looking statements

This announcement (including information incorporated by reference in this announcement), oral statements made regarding the sale of the Loan Book and of Duncan Lawrie Asset Management Limited (the "Disposals"), and other information published by Camellia plc contain statements which are, or may be deemed to be, "forward-looking statements". Forward-looking statements are prospective in nature and are not based on historical facts, but rather on current expectations and projections of the management of Camellia plc about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements.

The forward-looking statements contained in this announcement include statements relating to the expected effects of the Disposals on Camellia plc, the expected timing and scope of the Disposals and other statements other than historical facts. Often, but not always, forward-looking statements can be identified by the use of forward-looking words such as "plans", "expects" or "does not expect", "is expected", "is subject to", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. Although Camellia plc believes that the expectations reflected in such forward-looking statements are reasonable, Camellia plc can give no assurance that such expectations will prove to be correct. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements. Neither Camellia plc nor any of its associates or directors, officers or advisers, provides any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements in this announcement will actually occur. You are cautioned not to place undue reliance on these forward-looking statements. Other than in accordance with their legal or regulatory obligations, Camellia plc is not under any obligation, and Camellia plc expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISQKLBFQLFZFBF
Date   Source Headline
25th Apr 20247:00 amRNSDirector Changes
28th Mar 202412:11 pmRNSUpdate on BF&M disposal
4th Jan 20244:00 pmRNSRefocussing investments & Bardsley England update
27th Sep 202310:03 amRNSTrading Update
1st Sep 20235:21 pmRNSInterim Report 2023
1st Sep 20237:00 amRNSHalf-year Report
17th Jul 20237:00 amRNSDirector Changes
9th Jun 202312:08 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Trading Statement
6th Jun 202312:00 pmRNSSale of holding in BF&M Limited
11th May 202311:04 amRNSAnnual Report and Notice of AGM
4th May 20237:00 amRNSFinal Results
20th Mar 20237:00 amRNSChange of Registered Office Address
8th Mar 20237:00 amRNSTrading Update
30th Jan 20237:00 amRNSBF&M Strategic Review Conclusion
10th Jan 20239:01 amRNSCompletion of Disposal of ACS&T
19th Dec 20227:00 amRNSDisposal of ACS&T and Relocation of Head Office
7th Dec 20227:00 amRNSTrading Update
22nd Nov 20222:38 pmRNSTrading Update
6th Sep 20222:45 pmRNSInterim Report 2022 - Replacement
1st Sep 20224:00 pmRNSInterim Report 2022
1st Sep 20227:00 amRNSHalf-year Report
24th Aug 20227:00 amRNSTrading Update
1st Jul 202210:54 amRNSResults of Annual General Meeting - 30 June 2022
30th Jun 20227:00 amRNSBF&M Strategic Review
30th Jun 20227:00 amRNSAGM Trading Statement
9th Jun 202211:12 amRNSBoard Committee Changes
6th Jun 20225:22 pmRNSAnnual Report and Notice of AGM
31st May 20227:00 amRNSFinal Results
6th May 20227:00 amRNSDirector Changes and Trading Update
22nd Dec 20217:00 amRNSTrading Update
17th Nov 20217:00 amRNS100% Ownership of Bardsley England
2nd Nov 20217:00 amRNSDirectorate Change
2nd Sep 20212:36 pmRNSInterim Report 2021
2nd Sep 20217:00 amRNSHalf-year Report and changes to Board Committees
25th Aug 202112:42 pmRNSNotice of Interim Results
6th Aug 20218:30 amRNSDeath of Director
5th Aug 20217:00 amRNSSale of Abbey Metal Finishing
2nd Aug 20217:00 amRNSPurchase of Bardsley England
20th Jul 20212:00 pmRNSTrading Update
3rd Jun 20214:15 pmRNSResults of Annual General Meeting - 3 June 2021
3rd Jun 202112:00 pmRNSAGM Trading Statement
5th May 20214:00 pmRNSAnnual Report and Notice of AGM
4th May 20217:00 amRNSFinal Results and Directorate change
29th Apr 20214:30 pmRNSFinal Results - Date of Announcement
11th Feb 20218:00 amRNSTrading update and settlement of claims
16th Nov 20207:00 amRNSCompletion of asset disposal
2nd Nov 20207:15 amRNSGovernance changes
21st Oct 20204:04 pmRNSTrading update
12th Oct 20207:00 amRNSResponse to UK media reports on Kakuzi Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.